

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb271</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Efficient Media for High Lipase Production: One Variable at a Time Approach</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Soleymani</surname><given-names>Safoura</given-names></name></contrib><aff>Nanobiotechnology Research Center, Avicenna Research Institute (ACECR), Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Alizadeh</surname><given-names>Houri</given-names></name></contrib><aff>Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Mohammadian</surname><given-names>Hossein</given-names></name></contrib><aff>Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</aff><aff>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Rabbani</surname><given-names>Emad</given-names></name></contrib><aff>Department of Molecular Medicine, Faculty of Advanced Medical Technologies, Golestan University of Medical Sciences, Gorgan, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Moazen</surname><given-names>Fatemeh</given-names></name></contrib><aff>Reproductive Biotechnology Research Center, Avicenna Research Institute (ACECR), Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>MirMohammad Sadeghi</surname><given-names>Hamid</given-names></name></contrib><aff>Immunology Research Center (IRC), Tabriz University of Medical Science, Tabriz, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Samsam Shariat</surname><given-names>Ziaedin</given-names></name></contrib><aff>Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Etemadifar</surname><given-names>Zahra</given-names></name></contrib><aff>Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</aff><aff>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Rabbani</surname><given-names>Mohammed</given-names></name></contrib><aff>Reproductive Biotechnology Research Center, Avicenna Research Institute (ACECR), Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>9</volume>
      <issue>2</issue>
      <fpage>82</fpage>
      <lpage>86</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>6</month>
          <year>2016</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: Lipase enzymes have applications in a wide range of industries. A crucial determining factor of industrial prices of these enzymes is the culture media composition that is constantly under review by researchers. In this work, for maximum lipase production by &lt;em&gt;Bacillus sp. ZR-5&lt;/em&gt;, culture media compositions were optimized using &amp;quot;one variable at a time&amp;quot; strategy.&lt;br /&gt;
Methods: For this purpose, the culture medium parameters such as low and high cost carbon and nitrogen sources, substrates and incubation times were evaluated.&lt;br /&gt;
Results: Maximum lipase activity was achieved after 24&lt;em&gt; hr&lt;/em&gt; of incubation with 1.5% of glucose syrup (1600&amp;plusmn;69.1 &lt;em&gt;u/mg&lt;/em&gt;), 1% of fish powder (1238&amp;plusmn;36.7 &lt;em&gt;u/mg&lt;/em&gt;) and olive oil (1407&amp;plusmn;2.1 &lt;em&gt;u/mg&lt;/em&gt;) as low cost carbon and nitrogen sources and substrate, respectively.&lt;br /&gt;
Conclusion: Our results show a significant increase in lipase activity with usage of low cost sources; this could help in reducing the media prices for industrial application of lipase enzyme.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
